Ken studied for his PhD in protein biochemistry, enzyme regulation and reaction kinetics at The University of Birmingham in the UK and subsequently worked at Servier Research & Development’s UK research facility for seven years. Since 2001 Ken has worked in AstraZeneca’s Respiratory and Inflammation research labs in the UK and Sweden as DMPK project lead and in Project Leadership roles in pre-clinical projects, supporting many projects successfully through to clinical development. Ken has to date authored / co-authored over thirty papers and book chapters and is currently Senior Director of Drug Metabolism and Pharmacokinetics in AstraZeneca’s Respiratory Inflammation and Autoimmune disease innovative biotech unit in Gothenburg, Sweden.